Dynamics of DLGG and Clinical Implications

Oct 25, 2017 by in ONCOLOGY Comments Off on Dynamics of DLGG and Clinical Implications

Fig. 16.1 Illustrative case of pre- versus post-operative growth rates. Note that one can estimate the oncological gain of surgery: the re-evolution curve is translated by about 6 years. Note…

read more

Epilepsy and Diffuse Low-Grade Gliomas

Oct 25, 2017 by in ONCOLOGY Comments Off on Epilepsy and Diffuse Low-Grade Gliomas

Fig. 12.1 (a) Example of a left parietal diffuse low-grade glioma. Brain tissue specimens were sampled inside the tumor (Tu) and from the neocortex infiltrated by sparse glioma cells (Cx)….

read more

Epidemiology of Diffuse Low Grade Gliomas

Oct 25, 2017 by in ONCOLOGY Comments Off on Epidemiology of Diffuse Low Grade Gliomas

Diffuse astrocytic and oligodendroglial tumors ICD-O codes Diffuse astrocytoma, IDH-mutant 9400/3  Gemistocytic astrocytoma, IDH-mutant 9411/3 Diffuse astrocytoma, IDH-wildtype 9400/3 Diffuse astrocytoma, NOS 9400/3 Anaplastic astrocytoma, IDH-mutant 9401/3 Anaplastic astrocytoma, IDH-wildtype…

read more

The Origins of Diffuse Low-Grade Gliomas

Oct 25, 2017 by in ONCOLOGY Comments Off on The Origins of Diffuse Low-Grade Gliomas

Fig. 34.1 Tumor overlap map overlaid on a standard Montreal National Institute (MNI) T1 for all 198 patients, presented according to the neurological convention (left to left and right to…

read more
Get Clinical Tree app for offline access